SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

HBsAg Rapid Quantitative Test

HBsAg is the surface antigen of the hepatitis B virus (HBV). It indicates current hepatitis B infection. Biotime HBsAg Rapid Quantitative Test kit can detect the specimen of serum and plasma.

Cys-C Rapid Quantitative Test

Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

Dengue NS1 Antigen Rapid Test

The Dengue NS1 Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Dengue virus NS1 antigen in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with the dengue virus. For professional in vitro diagnostic use only.

CLi-1600 CLIA Analyzer

CLi-1600 semi-automated device which quantifies biomarkers for thyroid disease, inflammation, cardiac diseases, fertility, diabetes, bone metabolism, anemia, and health check by analyzing human serum, plasma and whole blood.

FLI-600 FIA Analyzer

FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.

Product Name	SARS-COV-2 Neutralizing Antibody Rapid Test
Sample Type	Serum/Plasma
Loading Volume	80 uL
Reaction Time	10 min
Interpretation of Results	Negative: <1.5 IU/ml；Positive: ≥1.5 IU/ml
Shelf Life	24 months
Storage Condition	2-30℃
Unit	25 kits/box

Solutions

Covid-19 Solution

SARS-CoV-2 Neutralizing Antibody Rapid Test